Late manifestation of fatal (Adamantiades-)behcet disease with cardiac involvement;Spatmanifestation eines morbus Adamantiades-behcet mit kardialer beteiligung und letalem ausgang

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 8, 1998, Pages 217-222

  Kaatz, M ^a   Gornig M ^a   Bocker, T ^a   Zouboulis, Ch C ^b   Wollina, U ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN A; DIGITOXIN; DIURETIC AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; NITRATE; PREDNISOLONE; ANTIINFLAMMATORY AGENT; CYCLOSPORIN;

AGED; ARTICLE; BEHCET DISEASE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CASE REPORT; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PNEUMONIA; RHEUMATIC DISEASE; CONGESTIVE CARDIOMYOPATHY; DRUG COMBINATION; ECHOGRAPHY; FATALITY; PATHOLOGY; RECURRENT DISEASE; SKIN;

AGED; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; BEHCET SYNDROME; CARDIOMYOPATHY, DILATED; CYCLOSPORINE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREDNISOLONE; RECURRENCE; SKIN;

EID: 0032548857     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023940     Document Type: Article

References (26)

1. Adamantiades, B.: La thrombophlebite comme quatrieme symptome de l'iritis recidivante a hypopyon. Ann. Oculist (Paris) 168 (1946), 271-278.
2. Adamantiades, B.: Sur un cas d'iritis á hypopyon récidivant. Ann. Oculist (Paris) 168 (1931), 271-278.
3. Avci, O., N. Gürler, A. T. Günes: Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease. J. Amer. Acad. Dermatol. 36 (1997), 796-797.
4. Behçet, H.: Über rezidivierende aphthöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol. Wschr. 105 (1937), 1152-1157.
5. Bowles, C. A., A. M. Nelson, S. C. Hammill, J. D. O'Duffy: Cardiac involvement in Behçet's disease. Arthritis Rheum. 28 (1985), 345-348.
6. Busch, R., T. Ruzicka, G. Donhauser: Cyclosporin-A-Therapie des Morbus Behçet. Hautarzt 41 (1990), 229-231.
7. Hashimoto, T., A. Takeuchi: Treatment of Behçet's disease. Curr. Opin. Rheumatol. 4 (1992), 31-34.
8. Ho, V. C., H. Lui, D. I. McLean: Cyclosporine in nonpsoriatic dermatoses. J. Amer. Acad. Dermatol. 23 (1990), 1248-1259.
9. International Study Group of Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 335 (1990), 1078-1080.
10. Jorizzo, J. L., J. L. Abernethy, W. L. White, H. Mangelsdorf, Ch. C. Zouboulis, R. Sarica, K. Gaffney, C. Mat, H. Yazici, A. Al Ialaan, S. H. Assad-Khalil, F. Kaneko, E. A. F. Jorizzo: Mucocutaneous criteria for the diagnosis of Behçet's disease. An analysis of clinicopathologic data from multiple international centers. J. Amer. Acad. Dermatol. 32 (1995), 968-976.
11. Kim, H. J., D. Bang, S. H. Lee, D. S. Yang, D. H. Kim, D. H. Lee, S. Lee, H. B. Kim, W. P. Hong: Behçet-syndrome in Korea. A look at the clinical picture. Yonsei Med J. 29 (1988), 72-78.
12. Masuda, K., A Urayama, M. Kogure, A. Kakajima, K. Nakae, G. Inaba: Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet 1989/I, 1093-1095.
13. Mrowietz, U.: Vorstellungen zum Wirkungsmechanismus von Ciclosporin bei der Psoriasis. Hautarzt 44 (1993), 353-360.
14. O'Duffy, J., D., N. P. Goldstein: Neurologic involvement in seven patients with Behçet's disease. Amer. J. Med. 61 (1976), 170-178.
15. O'Duffy, J. D.: Comments. Bull. Rheum. Dis. 29 (1978), 977-979.
16. Pacor, M. L., D. Biasi, C. Lunardi, P. Cortina, P. Caramaschi, D. Girelli, M. Botto, G. Urbani, G. Lombardo, L. M. Bambara: Cyclosporine in Behçet's disease. Results in 16 patients after 24 months of therapy. Clin. Rheumatol. 13 (1994), 224-227.
17. Pena, M., J. Garcia-Alegria, F. Garcia-Fernandez, F. Arnalich, F. J. Barbara, J. J. Vasquez: Mitral and aortic regurgitation in Behçet's syndrome. Ann. Rheum. Dis. 44 (1985), 637-639.
18. Rolland, J. M., O. Bical, A. Laradi, G. Robinault, R. Benzidia, A. Vanetti, G. Herreman: False aneurysm of the left ventricle and coronary aneurysms in Behçet's disease. Arch. Mal. Coeur. Vaiss. 86 (1993), 1383-1385.
19. Routy, J. P., A. P. Blanc, C. Viallet, F. Lejeune, E. Lagier, H. Chardon: A rare cause of arthritis, Behçet's disease in a HIV-positive subject, 69 years of age. Nouv. Presse méd. 18 (1989), 1799.
20. Sorensen, B., F. Collet, P. Rossi, R. Gerard: Maladie de Behçet et pathologie cardiovasculaire. Ann. Cardiol. Angéiol 34 (1985), 495-497.
21. Süß, R., M. Al-Ayoubi, T. Ruzicka: Cyclosporine in Behçet's disease. J. Amer. Dermatol. 29 (1993), 101-102.
22. Treudler, R., Ch. C. Zouboulis, P. Büttner, M. Detmar, C. E. Orfanos: Enhanced interaction of patient's lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behçet's disease. Arch. Dermatol. 132 (1996), 1323-1329.
23. Yazici, H., Y. Tuzun, H. Parzarli, S. Yurdakul, Y. Ozyazgan, H. Ozdogan, S. Serdaroglu, M. Ersanli, B. Y. Ulku, A. U. Moftuoglu: Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann. Rheum. Dis. 43 (1984), 783-789.
24. Zouboulis, Ch. C., K. Kurz, B. Bratzke, C. E. Orfanos: Morbus Adamantiades-Behçet: Nekrotisierende Systemvaskulitis mit letalem Ausgang. Hautarzt 42 (1991), 451-454.
25. Zouboulis, Ch. C.: Morbus Adamantiades-Behçet in Deutschland. Historischer Rückblick und aktueller Kenntnisstand. Z. Hautkr. 71 (1996), 491-501.
26. Zouboulis, Ch. C.: Morbus Adamantiades-Behçet. Klinische und experimentelle Befunde von 53 Patienten aus dem Berliner Raum. Habilitationsschrift (1995) Universitäts-Hautklinik und Poliklinik, Klinikum Benjamin Franklin der Freien Universität Berlin.